Featured Research

from universities, journals, and other organizations

Millions with peripheral artery disease not getting vital medications, study finds

Date:
June 21, 2011
Source:
American Heart Association
Summary:
Millions of adults with peripheral artery disease are not receiving the medications needed to reduce their risk of heart attack, stroke and death, according to new research.

Millions of adults with peripheral artery disease are not receiving the medications needed to reduce their risk of heart attack, stroke and death, according to research in Circulation: Journal of the American Heart Association.

Most patients are not receiving recommended therapies such as cholesterol and blood pressure-lowering medications, the study's authors found. Peripheral artery disease is the result of atherosclerosis, or blockages in the arteries in the legs caused by plaque. People with this disease have a significantly increased risk of having either a non-fatal or fatal heart attack or stroke because atherosclerosis can also affect the arteries supplying blood to the heart and brain.

Of the estimated 7.1 million U.S. adults with peripheral artery disease, also known as PAD, the study found:

  • Two in three, or about 5 million, are not taking cholesterol-lowering medications.
  • Nearly three in four, or about 5.4 million, are not receiving angiotensin converting enzyme inhibitors or angiotensin receptor blockers, which are blood pressure-lowering medications.
  • Two in three, or about 4.5 million, are not taking aspirin, which may reduce the risk of heart attack.

"We found that taking two or more of these medications was associated with a 65 percent lower rate of death from all causes," said Reena L. Pande, M.D., study lead author and an instructor at the Harvard Medical School in Boston. "The study tells us that millions of individuals identified with PAD by a simple non-invasive screening test are not receiving medications that may reduce their risk of death."

The most common symptom of PAD is a painful muscle cramping in the hips, thighs or calves when walking, climbing stairs or exercising. This can be treated with medications, exercise therapy or restoring blood flow by surgical revascularization procedures. The increased risk of fatal or non-fatal heart attacks and strokes for individuals with PAD can be modified by using medications, such as statins and aspirin, said Pande who is also an associate physician in the cardiovascular division of Brigham and Women's Hospital in Boston.

In this study, researchers used a simple screening test -- ankle brachial index -- to identify whether people who have PAD, but no known heart disease, would benefit from medications to reduce the risk of cardiovascular events.

The ankle brachial index is a comparison between the blood pressure in an individual's arm and the blood pressure in their ankle. A low number indicates that the arteries in the legs might be narrowed, which impedes blood flow and can indicate a high risk of heart disease and stroke.

Researchers studied data from 7,458 adults from 1999 to 2004, using the National Health and Nutrition Examination Survey, to determine how many of these asymptomatic individuals were not taking medications to lower their risk of heart attack and stroke, and whether taking these medications resulted in lower death rates.

The data used for this analysis did not provide information that would explain the reasons why these patients were not receiving the risk lowering therapies, but the study suggests that identification of PAD using ABI test screening might make physicians aware of the diagnosis of PAD and make them more likely to prescribe these medications.

Pande noted that these findings are observational, which means the researchers analyzed existing data. The conclusions from this study need to be repeated in larger trials that are designed specifically to validate these results, before scientists and physicians can begin to examine how best to address the issue of providing risk lowering treatments for asymptomatic patients with PAD.

Co-authors are Todd S. Perlstein, M.D., M.M.Sc.; Joshua A. Beckman, M.D., M.Sc.; and Mark A. Creager, M.D. Pande and Perlstein have received support from the National Heart, Lung, and Blood Institute. Pande has also received funding from the American Heart Association.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Journal Reference:

  1. Reena L. Pande, Todd S. Perlstein, Joshua A. Beckman, Mark A. Creager. Secondary Prevention and Mortality in Peripheral Artery Disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation, 2011; DOI: 10.1161/CIRCULATIONAHA.110.003954

Cite This Page:

American Heart Association. "Millions with peripheral artery disease not getting vital medications, study finds." ScienceDaily. ScienceDaily, 21 June 2011. <www.sciencedaily.com/releases/2011/06/110620161202.htm>.
American Heart Association. (2011, June 21). Millions with peripheral artery disease not getting vital medications, study finds. ScienceDaily. Retrieved October 2, 2014 from www.sciencedaily.com/releases/2011/06/110620161202.htm
American Heart Association. "Millions with peripheral artery disease not getting vital medications, study finds." ScienceDaily. www.sciencedaily.com/releases/2011/06/110620161202.htm (accessed October 2, 2014).

Share This



More Health & Medicine News

Thursday, October 2, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pregnancy Spacing Could Have Big Impact On Autism Risks

Pregnancy Spacing Could Have Big Impact On Autism Risks

Newsy (Oct. 1, 2014) A new study says children born less than one year and more than five years after a sibling can have an increased risk for autism. Video provided by Newsy
Powered by NewsLook.com
Robotic Hair Restoration

Robotic Hair Restoration

Ivanhoe (Oct. 1, 2014) A new robotic procedure is changing the way we transplant hair. The ARTAS robot leaves no linear scarring and provides more natural results. Video provided by Ivanhoe
Powered by NewsLook.com
Insertable Cardiac Monitor

Insertable Cardiac Monitor

Ivanhoe (Oct. 1, 2014) A heart monitor the size of a paperclip that can save your life. The “Reveal Linq” allows a doctor to monitor patients with A-Fib on a continuous basis for up to 3 years! Video provided by Ivanhoe
Powered by NewsLook.com
Attacking Superbugs

Attacking Superbugs

Ivanhoe (Oct. 1, 2014) Two weapons hospitals can use to attack superbugs. Scientists in Ireland created a new gel resistant to superbugs, and a robot that can disinfect a room in minutes. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins